Serum Peroxiredoxin3 is a Useful Biomarker for Early Diagnosis and Assessemnt of Prognosis of Hepatocellular Carcinoma in Chinese Patients

MACC1 Expression Correlates with PFKFB2 and Survival in Hepatocellular Carcinoma

(2014) Dong Ji et al.   Asian Pacific Journal of Cancer Prevention

Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis

(2013) Jia Fu et al.   CANCER SCIENCE

Hepatozelluläres Karzinom - molekulare Grundlagen und Zielmoleküle für die Therapie

(2012) J. Marquardt et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

(2012) Qiujin Shen et al.   LANCET ONCOLOGY

Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis

(2012) Lili Liu et al.   PLoS One

Peroxiredoxin 3 Is a Key Molecule Regulating Adipocyte Oxidative Stress, Mitochondrial Biogenesis, and Adipokine Expression

(2011) Joo Young Huh et al.   ANTIOXIDANTS & REDOX SIGNALING

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Strategies for hepatocellular carcinoma therapy and diagnostics: Lessons learned from high throughput and profiling approaches

(2011) Kai Breuhahn et al.   HEPATOLOGY

Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy

(2011) In-Sung Song et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma

(2011) Masayasu Jo et al.   JOURNAL OF GASTROENTEROLOGY

Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview

(2011) Monica Marra et al.   Journal of Translational Medicine

The role of enoyl-CoA hydratase short chain 1 and peroxiredoxin 3 in PP2-induced apoptosis in human breast cancer MCF-7 cells

(2010) Xiang Liu et al.   FEBS LETTERS

Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma

(2010) Yilei Mao et al.   GUT

AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC

(2010) Kentaroh Yamamoto et al.   JOURNAL OF GASTROENTEROLOGY

Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4

(2010) Anamika Basu et al.   PROSTATE

Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines

(2010) Zhiqin Dai et al.   PROTEOMICS

Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

(2009) Sean F. Altekruse et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

(2009) Dunyaporn Trachootham et al.   NATURE REVIEWS DRUG DISCOVERY

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics

(2009) Mohamed IF Shariff et al.   Expert Review of Gastroenterology & Hepatology

Proteomic identification of tumor-associated protein in ovarian serous cystadenocarinoma

(2008) Xiu-Qin Li et al.   CANCER LETTERS